and A. M. Budy, p. 107. Chicago, University of Chicago Press. Zisman, E., et al. (1968) . American Journal of Medicine, 45, 619. Metabolic Studies, Aldosterone Secretion Rate, and Plasma Renin after Carbenoxolone Sodium R. TUFFLEY,4 M.B., B.S., M.R.C.P. British Medical Journal, 1969, 2, 793-795 Summary: A formal metabolic study of carbenoxolone sodium (Biogastrone) 300 mg./day has been performed for 17 days on a woman with gastric ulcer who in a previous 21-day trial, on a 52-mEq sodium diet, showed weight gain, retention, and rise in plasma sodium and chloride concentrations, as well as hypokalaemia without change in potassium balance. In the present trial sodium intake was restricted to 26 mEq/day; while plasma electrolyte changes of lesser degree still occurred, there was no retention of water, sodium, or chloride. Aldosterone secretion in the control period was 202 ttg./24 hours, and fell to 74 ttg./24 hours after carbenoxolone, but plasma renin was unchanged.
These results suggest that the mineralocorticoid effects of carbenoxolone (and presumably of liquorice and its other derivatives) are due to an intrinsic aldosterone-like action, and that, with sodium deprivation, aldosterone secretion is suppressed by a mechanism which is not renin-mediated-possibly hypokalaemia.
Introduction
We have previously reported detailed studies of the metabolic changes resulting from the administration of carbenoxolone sodium (Biogastrone), 300 mg./day for 21 days, to four patients with peptic ulcer (Baron and Nabarro, 1968 After a five-day run-in period an eight-day control period of observation was made, followed by 17 days on carbenoxolone sodium as Biogastrone tablets 100 mg. three times a day before meals. On the last two days of the control period and the last two days of the drug period the following additional procedures were carried out. On the first of the two days at 8 a.m., with the patient fasting and supine, not having been out of bed from the previous night, 20 ml. of blood was withdrawn from a vein, heparinized, centrifuged, and the plasma separated and frozen. About 3 1,Ci of i.2H3-(d + )-aldosterone-17,6 was then injected intravenously. At 3 p.m., after the patient had been standing and walking for half an hour, a further 20 ml. of venous blood was taken. Urine was collected for 48 hours for determination of the aldosterone secretion rate from the specific activity of the acid-labile metabolite . Plasma renin was measured by an enzyme kinetic method Tuffley and Slater, 1969) .
Results
No clinical side-effects were observed. The If liquorice or its derivatives stimulated the adrenal to produce aldosterone, or inhibited aldosterone metabolism, a rise in aldosterone excretion would be expected. If liquorice or derivatives have aldosterone-like action aldosterone excretion will be suppressed. The published results in man for liquorice and glycyrrhizinic acid are consistent; there is normal or reduced aldosterone excretion (Mollaret, Goulon, and Tournilhac, 1960; Drosdowski, Robel, and Sebaoun, 1961 ; Garcin, Goulon, Tournilhac, and Amor, 1961 ; Jenny, Muller, Fabre, and Mach, 1961 ; Salassa, Mattox, and Rosevear, 1962 ; Minivielle, Cristol, and Badach, 1963; Conn, Rovner, and Cohen, 1968) and secretion (Jenny et al., 1961 ; Conn et al., 1968) . Plasma renin activity is also suppressed (Conn et al., 1968) . These changes are reversible on stopping the liquorice preparations and can be produced again by restarting them.
The results reported here with carbenoxolone, a glycyrrhetinic acid salt, as well as the reports with glycyrrhizinic acid or liqiorice, are consistent only with the hypothesis that the mineralocorticoid effect of carbenoxolone is due to its possessing intrinsic aldosterone-like properties. The unchanged morning plasma renin activity after earbenoxolone would suggest that the suppression of aldosterone secretion by carbenoxolone is not renin-mediated. It is most unlikely that a change in A.C.T.H. secretion was responsible for this fall in aldosterone secretion, since liquorice and its derivatives have little or no glucocorticoid activity (Baron and Nabarro, 1968, p. 150) . We therefore suggest that this fall in aldosterone secretion is related to the fall in plasma potassium concentration (Laragh and Stoerk, 1957 ). Since we did not observe any change in external potassium balance our results suggest that aldosterone secretion is related to potassium concentration outside cells rather than inside cells.
The side-effects of carbenoxolone can be related to its mineralocorticoid effect and can be prevented by simultaneous administration of spironolactone, though at the cost of loss of therapeutic effect of ulcer-healing (Doll, Langman, and Shawdon, 1968) . The side-effects could also be lessened by the diuretic hydrochlorothiazide without loss of ulcer-healing effect but at the expense of potassium depletion (Doll et al., 1968) , and it is likely that a restricted sodium intake would prevent side-effects of carbenoxolone without loss of healing powers and without potassium depletion. embolic complications after the insertion of cardiac valve prostheses, platelet adhesiveness and aggregation was measured in whole blood before, during, and for several days after this operation in 10 patients. Cardiopulmonary bypass resulted in a profound decrease in the platelet count, in the number of adhesive platelets, and in platelet aggregation. These changes returned to near preoperative levels by the sixth postoperative day. Thereafter a consistent and sustained increase in platelet count, in the number of adhesive platelets, and in platelet aggregation was observed. The results suggest that the prevalence of thromboembolism after valve replacement may be due partly to changes in platelet behaviour.
Introduction
The operative mortality of acquired cardiac valvular disease has fallen in recent years. Nevertheless, several detailed follow-up studies have shown an alarming incidence of both fatal and non-fatal postoperative arterial thromboembolic complications (Table I) . From these studies it is clear that thromboembolic complications comprise the most important factor responsible for the delayed mortality and morbidity after heart valve replacement.
The role of platelets in thrombosis has been recognized for many years, and abnormalities in platelet behaviour have been shown to follow surgical operations (Wright, 1942; Emmons and Mitchell, 1965; Hampton and Mitchell, 1966; Bennett, 1967 ). Bygdeman et al. (1966 suggested that there is a correlation between the degree of increase in platelet adhesiveness and the subsequent development of venous thrombosis in surgical patients. Since patients undergoing open-heart surgery are exposed to a high risk of thromboembolic complications it appeared to be of value to examine their platelet response.
